Having trouble viewing this email? View in your browser.

Dear colleagues,
We are delighted to announce that Sanofi has organized a live symposium on influenza during the 34th Annual Meeting of the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which will be held in a hybrid format, both online and live on-site in Barcelona, Spain from April 27th to 30th 2024.
We look forward to your participation in person in Barcelona or virtually via the ECCMID platform!
April 29, 2024
8:30 - 10:00 am (CET) | Hall P
Aiming at a Moving Target With the Best flu Shot!
Welcome and Introductions
Changing Epidemiology of Influenza and Other Respiratory Viruses After the Covid-19 Pandemic and Implication for Future Vaccination Strategies
The Interplay Between Influenza Viruses and Streptococcus Pneumonia: How can Influenza end up With Bacterial Pneumonia and Contribute to AMR?
Evidence Synthesis and Using the GRADE Methodology for Assessing the Quality of Evidence and Formulating Recommendations
Prof. Nigar Sekercioglu, MD
Assistant Professor, Health Research Methods, Evidence and Impact Faculty of Health Sciences, McMaster University, Hamilton, Canada
Staff Physician at the Hamidiye Faculty of Medicine, Türkiye
Question and Answer Session
Closing Remarks
Dr. Frederick G. Hayden and Dr. Meral Akcay
We Can't Wait to Meet you at our Vibrant Sanofi Influenza Booth (#C13)!
Continue Your Influenza Journey With Sanofi on the Sanofi EVENT Platform - Click Here to Join!
These symposia are organized by Sanofi for healthcare professionals only. These sessions are not included in main conference CME/CPD credit.
Sanofi - MAT-GLB-2400555 (V1.0) March 2024
You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe here.